SecSonar.com

Alaunos Therapeutics, Inc. (TCRT)

Alaunos Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Alaunos Therapeutics, Inc. (TCRT) is a Biotechnology company based in US with a market capitalization of $7.4M. Revenue declined 50.0% year-over-year and free cash flow was negative at -$3M. This page tracks TCRT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 1 employees · IPO Aug 24, 2005

Valuation

Valuation & price

$2.47 · as of May 17, 2026 · -51.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.44

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.11$3.50$1.89Jul 25Dec 25Jul 26Jul 7, 25$5.11Jul 9, 25$5.01Jul 11, 25$4.99Jul 15, 25$3.38Jul 17, 25$3.26Jul 21, 25$3.10Jul 23, 25$3.10Jul 25, 25$2.81Jul 29, 25$2.77Jul 31, 25$2.85Aug 4, 25$3.02Aug 6, 25$2.84Aug 11, 25$2.54Aug 13, 25$2.39Aug 15, 25$2.25Aug 19, 25$2.24Aug 21, 25$1.89Aug 25, 25$1.97Aug 27, 25$1.89Aug 29, 25$2.13Sep 3, 25$2.24Sep 5, 25$2.16Sep 9, 25$2.30Sep 11, 25$2.38Sep 16, 25$2.32Sep 18, 25$2.50Sep 22, 25$2.48Sep 24, 25$2.85Sep 26, 25$2.50Sep 30, 25$2.41Oct 2, 25$2.63Oct 6, 25$2.54Oct 8, 25$3.70Oct 10, 25$3.48Oct 14, 25$3.44Oct 16, 25$3.10Oct 21, 25$2.77Oct 23, 25$2.71Oct 27, 25$2.89Oct 29, 25$2.72Oct 31, 25$2.72Nov 4, 25$2.52Nov 6, 25$2.46Nov 10, 25$2.53Nov 12, 25$2.99Nov 14, 25$2.97Nov 18, 25$3.34Nov 20, 25$3.55Nov 25, 25$3.45Nov 28, 25$3.34Dec 2, 25$3.28Dec 4, 25$3.59Dec 8, 25$4.09Dec 10, 25$4.31Dec 12, 25$4.26Dec 16, 25$4.36Dec 18, 25$3.98Dec 22, 25$3.63Dec 24, 25$3.52Dec 29, 25$3.44Jan 2, 26$3.28Jan 6, 26$3.20Jan 8, 26$3.54Jan 12, 26$2.85Jan 14, 26$2.74Jan 16, 26$3.08Jan 21, 26$3.00Jan 23, 26$2.93Jan 27, 26$2.95Jan 29, 26$2.75Feb 2, 26$2.75Feb 4, 26$2.45Feb 9, 26$2.69Feb 11, 26$2.64Feb 13, 26$2.57Feb 18, 26$2.58Feb 20, 26$2.72Feb 24, 26$2.85Feb 26, 26$3.14Mar 2, 26$3.32Mar 4, 26$3.36Mar 6, 26$3.61Mar 10, 26$3.49Mar 12, 26$3.19Mar 17, 26$3.12Mar 19, 26$3.31Mar 23, 26$3.20Mar 25, 26$3.01Mar 27, 26$2.98Mar 31, 26$2.86Apr 2, 26$2.93Apr 7, 26$2.92Apr 9, 26$2.83Apr 13, 26$2.96Apr 15, 26$2.89Apr 17, 26$2.92Apr 22, 26$2.73Apr 24, 26$2.76Apr 28, 26$2.59Apr 30, 26$2.55May 4, 26$2.53May 6, 26$2.63May 8, 26$2.58May 12, 26$2.63May 14, 26$2.52May 18, 26$2.46May 20, 26$2.40May 22, 26$2.42May 28, 26$3.06Jun 1, 26$2.87Jun 3, 26$2.62Jun 5, 26$2.28Jun 9, 26$1.99Jun 11, 26$2.21Jun 15, 26$2.28Jun 17, 26$2.22Jun 22, 26$2.16Jun 24, 26$2.15Jun 26, 26$2.08Jul 2, 26$2.08
$1.7752-week range$5.11
Loading valuation history…

Fundamentals

Key fundamentals

$7.4M

Market cap

-50.0%

Revenue growth (YoY)

100.0%

Gross margin

-$3M

Free cash flow (USD)

-$1.4M

Net debt

Net cash position

21.7%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$6.9MFY 2017$6.4MFY 2018$146.0KFY 2019$0.00FY 2020$0.00FY 2021$398.0KFY 2022$2.9MFY 2023$5.0KFY 2024$10.0KFY 2025$5.0K
$6.9M$5K

Free cash flow by year

2016 → 2025

FY 2016$-58.9MFY 2017$-55.4MFY 2018$-49.9MFY 2019$-41.1MFY 2020$-66.8MFY 2021$-64.8MFY 2022$-29.4MFY 2023$-30.3MFY 2024$-5.0MFY 2025$-3.0M
-$58.9M-$3M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023-95960.0%FY 2024100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.59)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventPreclinical Data AnnouncementJun 29, 2026Filing
  • 8-K eventPreclinical Study ResultsMay 26, 2026Filing
  • 8-K eventPreclinical Data AnnouncementMay 18, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • Annual report10-K FiledApr 30, 2026Filing
  • 8-K eventDelisting NoticeApr 15, 2026Filing
  • Annual report10-K FiledMar 31, 2026Filing

Questions

Frequently asked questions

What is Alaunos Therapeutics, Inc.'s market cap?

Alaunos Therapeutics, Inc. (TCRT) has a market capitalization of $7.4M.

What is TCRT's P/E ratio?

A meaningful P/E ratio is not available for TCRT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TCRT's price-to-book (P/B) ratio?

TCRT trades at 3.44 times book value per share.

When did Alaunos Therapeutics, Inc. last report earnings?

TCRT last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying TCRT stock?

SEC Form 4 filings show no open-market insider buys at Alaunos Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

CRIS

Curis, Inc.

$7M

SYBX

Synlogic, Inc.

$7.8M

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

$6.7M

IMRN

Immuron Limited

$8.5M

APRE

Aprea Therapeutics, Inc.

$6.1M

EVGN

Evogene Ltd.

$6.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.